KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Current Deferred Revenue (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed Current Deferred Revenue for 11 consecutive years, with $12.7 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 18.81% to $12.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.7 million through Dec 2025, down 18.81% year-over-year, with the annual reading at $12.7 million for FY2025, 18.81% down from the prior year.
  • Current Deferred Revenue hit $12.7 million in Q4 2025 for Nu Skin Enterprises, down from $15.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $33.1 million in Q4 2021 to a low of $12.7 million in Q4 2025.
  • Historically, Current Deferred Revenue has averaged $21.8 million across 5 years, with a median of $20.3 million in 2023.
  • Biggest five-year swings in Current Deferred Revenue: fell 5.46% in 2021 and later decreased 24.82% in 2023.
  • Year by year, Current Deferred Revenue stood at $33.1 million in 2021, then decreased by 18.37% to $27.1 million in 2022, then fell by 24.82% to $20.3 million in 2023, then decreased by 22.86% to $15.7 million in 2024, then fell by 18.81% to $12.7 million in 2025.
  • Business Quant data shows Current Deferred Revenue for NUS at $12.7 million in Q4 2025, $15.7 million in Q4 2024, and $20.3 million in Q4 2023.